-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Avadel Pharmaceuticals Plc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Avadel Pharmaceuticals Plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.7M, a 74.3% increase year-over-year.
- Avadel Pharmaceuticals Plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$98.8M, a 16.2% increase year-over-year.
- Avadel Pharmaceuticals Plc annual Operating Income (Loss) for 2023 was -$138M, a 39.9% decline from 2022.
- Avadel Pharmaceuticals Plc annual Operating Income (Loss) for 2022 was -$98.6M, a 15.2% decline from 2021.
- Avadel Pharmaceuticals Plc annual Operating Income (Loss) for 2021 was -$85.5M, a 1571% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)